Edward Seto

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Topics

Intellectual Disability

Histone Deacetylase

Top Venues

Cellular and molecular life sciences : CMLS

Cell death & disease

Life science alliance

This page only lists publications with an associated author ORCID identifier.

Publications

Hongbo Ling, Yixuan Li, Changmin Peng, Shengyu Yang, Edward Seto
HDAC10 inhibition represses melanoma cell growth and BRAF inhibitor resistance via upregulating SPARC expression. NAR cancer 6 (2) (2024)
Hongbo Ling, Yixuan Li, Changmin Peng, Shengyu Yang, Edward Seto
HDAC10 inhibition represses melanoma cell growth and BRAF inhibitor resistance via upregulating SPARC expression. NAR cancer 6 (2) (2024)
Hongbo Ling, Yixuan Li, Changmin Peng, Shengyu Yang, Edward Seto
HDAC10 inhibition represses melanoma cell growth and BRAF inhibitor resistance via upregulating SPARC expression. NAR cancer 6 (2) (2024)
Hongbo Ling, Yixuan Li, Changmin Peng, Shengyu Yang, Edward Seto
HDAC10 inhibition represses melanoma cell growth and BRAF inhibitor resistance via upregulating SPARC expression. NAR cancer 6 (2) (2024)
Sonali Bahl, Hongbo Ling, Nuwan P N Acharige, Irene Santos-Barriopedro, Mary Kay H Pflum, Edward Seto
EGFR phosphorylates HDAC1 to regulate its expression and anti-apoptotic function. Cell death & disease 12 (5) (2021)
Sonali Bahl, Edward Seto
Regulation of histone deacetylase activities and functions by phosphorylation and its physiological relevance. Cellular and molecular life sciences : CMLS 78 (2) (2020)
Lei Sun, Elphine Telles, Molly Karl, Fengdong Cheng, Noreen Luetteke, Eduardo M Sotomayor, Robert H Miller, Edward Seto
Loss of HDAC11 ameliorates clinical symptoms in a multiple sclerosis mouse model. Life science alliance 1 (5) (2018)